SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
ALISO VIEJO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held ophthalmic biotechnology company, today announced the appointment of Chetan Pujara, Ph.D., as Chief Research & Development Officer. Dr. Pujara brings over 20 years of leadership experience in pharmaceutical and drug-device combination product development across ophthalmic, neurological, dermatological and infectious disease areas. “Dr. Pujara is a distinguished leader with deep expertise in pharmaceutical innovation and drug development,” said Patrick Mooney, SpyGlass Pharma Chief Executive Officer. “He will be an invaluable resource as we continue to advance our proprietary intraocular drug delivery platform into Phase 3 trials. We ar
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- AbbVie to Host First-Quarter 2025 Earnings Conference CallPR Newswire
- Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades. [Yahoo! Finance]Yahoo! Finance
- Regulatory Condition Satisfied for License Agreement between AbbVie and Gubra [Yahoo! Finance]Yahoo! Finance
- AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025 [Yahoo! Finance]Yahoo! Finance
- AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025PR Newswire
ABBV
Earnings
- 1/31/25 - Beat
ABBV
Sec Filings
- 3/25/25 - Form ARS
- 3/24/25 - Form DEFA14A
- 3/24/25 - Form DEF
- ABBV's page on the SEC website